| ||
| Study: Pfizer lung cancer pill may double survival Bismarck Tribune By LINDA A. JOHNSON | Posted: Sunday, June 5, 2011 3:03 pm | (0) Comments A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according to ... See all stories on this topic » |
| ||
| Information obtained from ClinicalTrials.gov on June 02, 2011 Link ... ... BB-C03-IVB/173 NCI-V96-1113 NCT00002911 Marimastat in Treating Patients With Stage III Non-Small Cell Lung Cancer A PHASE III, MULTI-CENTER, RANDOMIZED, ... clinicaltrials.gov/show/NCT00002911?displayxml=true | ||
| Surviving early stage lung cancer - Surviving early stage lung cancer In Stage 0 of lung cancer progression, there is limited. Chemotherapy in Early- stage Lung Cancer. Christopher G. Azzoli, MD, Thoracic in stage II to III ... pyjyox.xt.pl/Uxz09/ | ||
| All Sad and scared messages My dad has stage 3 lung cancer and after his 2nd round of chemo it left him very weak to the the point they had to stop chemo and only do radiation. ... 12.106.186.179/message-board/message/all,57963,0.htm?... |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment